Testing cognitive function in elderly populations: the PROSPER studyObjectives: For large scale follow up studies with non-demented patients in which
cognition is an end- point, there is a need ... Methods: In the PROspective Study
of Pravastatin in the Elderly at Risk (PROSPER), 5804 elderly sub- jects aged 70
to .... a double blind, placebo controlled design.6 All subjects have had or are at ...Aspirin treatment hampers the use of plasma ... - Semantic ScholarSuch a study design is of more clinical significance, since in humans lesions
have already been ... Collins R, Simes R. Efficacy and safety of cholesterol-
lowering treatment: prospective meta- analysis of data ..... pravastatin additively
reduce development of atherosclerosis in APOE*3Leiden transgenic mice. J.
Hypertens ...
